PTE News and Press, PolarityTE Inc. From 09/18/20

Shares of Co-Diagnostics (NASDAQ: CODX) have bounced around a bit this year, to say the least. At the start of the year, you could buy a share in the Salt Lake City-based molecular diagnostics company for less than a dollar. By Aug. 8, the price was $30.80 after the company announced it was...

PolarityTE, Inc. (Nasdaq: PTE) today announced cost per product data from the protocol-specified interim analysis in the Company’s ongoing randomized controlled trial (RCT) evaluating SkinTE for the treatment of diabetic foot ulcers (DFUs), which previously reported statistically sig...

PolarityTE (NASDAQ: PTE )   expects Q3 2020 revenues to meet or exceed top end of  previous guided range of $2.7M-3.2M. More news on: PolarityTE, Inc., Stocks on the move Read more ...

PolarityTE, Inc. (Nasdaq: PTE) today announced that third quarter 2020 revenues will likely meet or exceed top end of the previous guided range of $2.7M to $3.2M. David Seaburg, CEO, commented, “We continue to see strong execution and momentum in SkinTE sales. Further, we expect t...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and the Cantor Virtual Global Healthcare Conference on...

Slack Technologies (NYSE: WORK )   -17%  as Q2 billings disappoint . More news on: Slack Technologies, Inc., Hycroft Mining Holding Corporation, NextDecade Corporation, Stocks on the move, , Read more ...

Penny Stocks To Watch Today After Big Updates When it comes to finding some of the top penny stocks today , what are you looking for? Some might search for premarket momentum while others take a different approach. These traders look at certain fundamental catalysts. Whether it’s a co...

PolarityTE (NASDAQ: PTE )  subsidiary, Arches Research has entered into a strategic partnership with Co-Diagnostics (NASDAQ: CODX ) to expand COVID-19 testing operations. More news on: Co-Diagnostics, Inc., PolarityTE, Inc., Healthcare stocks news, Read more ...

Albireo Pharma (NASDAQ: ALBO ) +82%  as odevixibat successful in late-stage study. More news on: Albireo Pharma, Inc., Nikola Corporation, Luby's, Inc., Stocks on the move, , Read more ...

SALT LAKE CITY , Sept. 8, 2020 /PRNewswire/ -- Co-Diagnostics, Inc.   (Nasdaq: CODX), (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today announced that it has entered into an agreement with Arches Resear...